Amphastar Pharmaceuticals
AMPH
AMPH
135 hedge funds and large institutions have $458M invested in Amphastar Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 58 increasing their positions, 39 reducing their positions, and 18 closing their positions.
Holders
135
Holders Change
+1
Holders Change %
+0.75%
% of All Funds
2.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
58
Reduced
39
Closed
18
Calls
$221K
Puts
–
Net Calls
+$221K
Net Calls Change
+$221K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$7.68M |
| 2 |
2
Arrowstreet Capital
Boston,
Massachusetts
|
$3.08M |
| 3 |
3
Renaissance Technologies
New York
|
$9.02M |
| 4 |
4
Federated Hermes
Pittsburgh,
Pennsylvania
|
$30.1M |
| 5 |
5
Goldman Sachs
New York
|
$4.23M |
Top Sellers
| 1 |
1
Invesco
Atlanta,
Georgia
|
$17.7M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$175K |
| 3 |
3
Millennium Management
New York
|
$420K |
| 4 |
EI
4
EAM Investors
Solana Beach,
California
|
$0 |
| 5 |
5
BlackRock
New York
|
$119M |
